Red blood cell lysis solution
The invention provides a lysis reagent for lysing red blood cells, thereby releasing a target, such as RNA from a parasitic organism, in a form suitable for analysis. The reagent includes at least ammonium chloride and an anionic detergent, and may include an anti-coagulant. The reagent serves to lyse red blood cells, protect the released target from degradation in the lysate, and is compatible with subsequent steps for analysis of the target such as target capture, amplification, detection, or sequencing.
1. A reagent comprising ammonium chloride at a concentration of 200-300 mM and lithium lauryl sulfate (LLS) at a concentration of 4% to 15% (w/v).
2. The reagent of claim 1 , further comprising sodium bicarbonate buffer.
3. The reagent of claim 2 , wherein the pH of the buffer is 7-8.
4. The reagent of claim 1 , further comprising an anti-coagulant.
5. The reagent of claim 4 , wherein the anti-coagulant is EDTA, heparin, or citrate.
6. The reagent of claim 1 , wherein the concentration of ammonium chloride is 250 mM.
7. The reagent of claim 1 , wherein the concentration of LLS is 5-8% (w/v).
8. The reagent of claim 1 , wherein the concentration of LLS is 5% (w/v).
9. The reagent of claim 1 , wherein the reagent is admixed with red blood cells or products derived from red blood cells.
10. The reagent of claim 1 , wherein the reagent is admixed with whole blood.
11. A reagent comprising ammonium chloride at a concentration of 200-300 mM, lithium lauryl sulfate (LLS) at a concentration of 4% to 15% (w/v), and sodium bicarbonate buffer at a concentration of 10-20 mM.
12. The reagent of claim 11 , wherein the pH of the buffer is 7-8.
13. The reagent of claim 11 , wherein the reagent further comprises an anti-coagulant.
14. The reagent of claim 11 , wherein the concentration of lithium lauryl sulfate (LLS) is 5% to 8% (w/v).
15. A kit comprising:
the reagent of claim 1 , and
at least two primers for performing an amplification assay on a target RNA to be isolated from red blood cells.
16. The kit of claim 15 , wherein the at least two primers are for performing transcription-mediated amplification of the target RNA.
17. The kit of claim 15 , further comprising a capture probe and an immobilized probe, wherein the capture probe comprises a first segment complementary to the target RNA and a second segment complementary to the immobilized probe.
18. The kit of claim 15 , wherein the target RNA is a pathogen-derived target.
19. The kit of claim 18 , wherein the target RNA is 18S rRNA from a pathogenic organism of the genus Babesia.